LAVAL, Quebec— Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT) announced financial results for the third quarter (3Q), ended Nov. 30, 2009. Nutraceutical business revenue for the three- and nine-month periods ended Nov. 30 were $3.76 million and $7.97 million, compared to $2.41 million and $7.87 million for the comparable 2008 periods, respectively. EBITDA was significantly up for 3Q in 2009 ($874,000), and only slightly down for the nine-month 2009 period (down $87,000). Comprehensive net income or loss for the three- and nine-month 2009 periods were a gain of $320,000 and a loss of $2,234,000, respectively.
Andre Godin, vice president, administration and finance, said, “We are extremely pleased with the way revenues and profitability markers have caught up and surpassed last year figures despite the first quarter shut down and second quarter ramp up following plant capacity increase, we are looking forward to maintained this trend for the future.”